Your browser doesn't support javascript.
loading
A case report of the sustained and rapid response of bevacizumab in a TP53-positive breast cancer and liver metastatic patient through personalized medicine.
Eskandarion, Mohammad Reza; Tizmaghz, Zahra; Andalib, Bahram; Parsa, Nasser; Emami, Seyed Amir Hossein; Shahsiah, Reza; Oghabian, Mohammad Ali; Shirkoohi, Reza.
Afiliación
  • Eskandarion MR; Cancer Research Center, Cancer Institute, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran.
  • Tizmaghz Z; BESTforPM (Biomarker Evaluation and Supervision Team for Personalized Medicine), Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran.
  • Andalib B; BESTforPM (Biomarker Evaluation and Supervision Team for Personalized Medicine), Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran.
  • Parsa N; Department of Radiation Oncology, Cancer Institute, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran.
  • Emami SAH; BESTforPM (Biomarker Evaluation and Supervision Team for Personalized Medicine), Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran.
  • Shahsiah R; Radiation Oncology Central Clinic of Karaj (ROCK), Karaj, Iran.
  • Oghabian MA; BESTforPM (Biomarker Evaluation and Supervision Team for Personalized Medicine), Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran.
  • Shirkoohi R; Iranian Cancer Association, Tehran, Iran.
Front Oncol ; 12: 940678, 2022.
Article en En | MEDLINE | ID: mdl-36119510
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Front Oncol Año: 2022 Tipo del documento: Article País de afiliación: Irán
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Front Oncol Año: 2022 Tipo del documento: Article País de afiliación: Irán